A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapy.

Suter A, Bickel M, Depmeier C, Gute P, Knecht G, Stöckle M, Fux C, Flury BB, Schmid P, Vernazza P, Kahlert CR

Open source

DOI
10.1371/journal.pone.0351576
Published
2026
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0351576,
  title = {A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapy.},
  author = {Suter A and Bickel M and Depmeier C and Gute P and Knecht G and Stöckle M and Fux C and Flury BB and Schmid P and Vernazza P and Kahlert CR},
  year = {2026},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0351576},
  url = {https://doi.org/10.1371/journal.pone.0351576}
}

RIS

TY  - JOUR
TI  - A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapy.
AU  - Suter A
AU  - Bickel M
AU  - Depmeier C
AU  - Gute P
AU  - Knecht G
AU  - Stöckle M
AU  - Fux C
AU  - Flury BB
AU  - Schmid P
AU  - Vernazza P
AU  - Kahlert CR
PY  - 2026
JO  - PloS one
DO  - 10.1371/journal.pone.0351576
UR  - https://doi.org/10.1371/journal.pone.0351576
ER  - 

APA

A, S., M, B., C, D., P, G., G, K., M, S., C, F., BB, F., P, S., P, V., & CR, K. (2026). A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapy.. PloS one. https://doi.org/10.1371/journal.pone.0351576

Source records